30 reports

Global Cancer Biomarkers Market 2015-2019

89 pages • By Infiniti Research Limited

About Cancer BiomarkersBiomarkers are molecules present in the blood, other body fluids such as serum, urine, or in tissue that are indicators of a disease or abnormal conditions. Biomarkers are mostly used as diagnostic tools. Biomarkers help in identifying potential drug failures in initial stages, leading to savings in time and costs....

2 000 2 500 1 600
Jan 2015

Renal Biomarkers: Technologies and Global Markets

90 pages • By BCC Research

REPORT HIGHLIGHTSThe in vitro diagnostic renal biomarker market was valued at $771 million in 2013 and $812 million in 2014. The market is expected to reach $1.1 billion by 2019, a compound annual growth rate (CAGR) of 7% from 2014 to 2019.This report provides:A comprehensive analysis of renal biomarkers...

5 320 6 650 4 256
Jan 2015

Personalized Medicine Partnering Terms and Agreements

1289 pages • By Currentpartnering

Comprehensive understanding and unprecedented access to the personalized medicine partnering deals and agreements entered into by the worlds leading healthcare companies. The Personalized Medicine Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the personalized medicine partnering...

2 636 3 295 2 109
Nov 2014

Biomarker Partnering Terms and Agreements

1048 pages • By Currentpartnering

The Biomarker Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the biomarker partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in biomarker partnering dealsBiomarker partnering agreement structureBiomarker partnering contract...

2 396 2 995 1 917
Nov 2014

Companion Diagnostics Partnering Terms & Agreements

455 pages • By Currentpartnering

The Companion Diagnostics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the companion diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter...

1 596 1 995 1 277
Nov 2014

miRNA Research and Diagnostics Markets

200 pages • By Kalorama Information

This report considers the diagnostic promise of non-coding RNA molecules, with a particular focus on the microRNAs. miRNAs (MicroRNAs) are short, single stranded RNAs that regulate mRNA expression at the post-transcriptional level. These small bits of RNA, members of a class of non-translated molecules that do not produce protein, shut off...

2 396 2 995 1 917
Sep 2014

Proteomics Markets for Research and IVD Applications

461 pages • By Kalorama Information

This Kalorama Information report defines markets and identifies trends for proteomics applications, both in their research use and in IVD. Proteomics is the study of proteins, including the study of the structure and function of proteins. This includes the study of which proteins are expressed, when and where they are expressed, structure...

3 360 4 200 2 688
Sep 2014

Molecular Diagnostics in Infectious Disease Testing

451 pages • By TriMark Publications

This TriMark Publications report describes the specific segment of the in vitro diagnostics market known as molecular diagnostics testing for infectious disease. In the current medical diagnostics market, molecular diagnostics in infectious disease testing offers one of the most promising areas for growth and innovation. The confluence of...

2 720 3 400 2 176
Sep 2014

Personalized Medicine in Oncology Partnering Terms and Agreements

741 pages • By Currentpartnering

The Personalized Medicine in Oncology Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the personalized medicine in oncology partnering agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies...

2 396 2 995 1 917
Aug 2014

Biomarkers in Amyotrophic Lateral Sclerosis

By CHI Insight Pharma Reports

OverviewBiomarkers in Amyotrophic Lateral Sclerosis is focused on the biomarker identification and development in patients with Amyotrophic Lateral Sclerosis (ALS). As a spin-off of Biomarkers: Discovery and Development for a Diagnostic Approach to Neurodegenerative Disorders, this report focuses on the ALS space featured in...

559 699 447
Aug 2014

Biomarkers in Parkinsons Disease

By CHI Insight Pharma Reports

OverviewBiomarkers in Parkinson’s Disease is focused on the biomarker identification and development in patients with Parkinson’s Disease. As a spin-off of Biomarkers: Discovery and Development for a Diagnostic Approach to Neurodegenerative Disorders, this report focuses on the Parkinson’s Disease space featured in the parent...

559 699 447
Aug 2014

Biomarkers: Discovery and Development for a Diagnostic Approach to Neurodegenerative Disorders - Overview

179 pages • By CHI Insight Pharma Reports

Biomarkers: Discovery and Development for a Diagnostic Approach to Neurodegenerative Disorders has a focus in biomarkers for neurodegenerative diseases and diagnostic applications in development. Biomarkers have been a heavily studied topic of interest, and recently on the rise is the interest in neurodegenerative disorders. Although there...

1 996 2 495 1 597
Jul 2014

Biomarkers in Alzheimers Disease

95 pages • By CHI Insight Pharma Reports

OverviewBiomarkers in Alzheimer’s Disease is focused on the biomarker identification and development in patients with Alzheimer’s Disease. As a spin-off of Biomarkers: Discovery and Development for a Diagnostic Approach to Neurodegenerative Disorders, this report focuses on the Alzheimer’s Disease space featured in the parent report,...

559 699 447
Jul 2014

Companion Diagnostics Market (2nd Edition), 2014-2024

233 pages • By Roots Analysis Private Ltd.

INTRODUCTIONWith an influx of new technologies and increasing awareness about personalized medicine, the pharmaceutical industry has steadily started to adopt a more customized drug development model. The concept of companion diagnostics holds huge potential for pharma companies as well as medical community. This new approach...

1 519 1 899 1 215
Jun 2014

Companion Diagnostics in Personalized Medicine and Cancer Therapy

292 pages • By TriMark Publications

Companion diagnostics (CDx) refers to a particular clinical diagnostic test that is under evaluation and is specifically linked to a known drug therapy. This linkage could be important in the therapeutic application and clinical outcome of a drug, such as with personalized medicine for oncology patients. The molecular diagnostics field plays...

2 720 3 400 2 176
Jun 2014

Biomarkers: Technologies and Global Markets

169 pages • By BCC Research

REPORT HIGHLIGHTSThe global biomarkers market is expected to grow from $29.3 billion in 2013 to $53.6 billion in 2018, a compound annual growth rate (CAGR) of 12.8%.This report provides:An overview of the global market for biomarkers.Analyses of global market trends, with data from 2012 and 2013, and...

5 320 6 650 4 256
Apr 2014

Mass Spectrometry for Clinical Applications: Market Analysis and End User Survey

250 pages • By Kalorama Information

For capacity, accuracy, and specificity of analysis, the use of mass spectrometry in clinical diagnostics and clinical research has grown dramatically in recent years. This Kalorama Information report, Mass Spectrometry for Clinical Applications: Market Analysis and End User Survey, looks at the growth of Mass Spec systems being used in diagnostics...

3 520 4 400 2 816
Apr 2014

Biomarker Technology Platforms for Cancer Diagnoses and Therapies

399 pages • By TriMark Publications

Until superior therapeutic treatments are developed to prevent, treat and cure cancer, the best means of reducing mortality and morbidity in a disease this complex is early detection and diagnosis. In the major solid cancer types such as lung, breast, colon and prostate, long-term survival rates drop precipitously once metastatis has occurred....

2 720 3 400 2 176
Jan 2014

Biomarkers Market (Diagnostic Applications in Risk Assessment, Molecular Diagnostics, Disease Diagnosis, Drug Discovery & Development, Drug Formulation, Forensic Applications and Others) - Global Industry Analysis, Emerging Technologies, Competitive Intel

151 pages • By Allied Market Research

Biomarkers Market (Diagnostic Applications in Risk Assessment, Molecular Diagnostics, Disease Diagnosis, Drug Discovery & Development, Drug Formulation, Forensic Applications and Others) - Global Industry Analysis, Emerging Technologies, Competitive Intelligence, Growth Trends, Size, Share, Opportunities and Forecast, 2013 - 2020Biomarkers...

3 612 4 515 2 890
Dec 2013

Global Imaging Biomarkers Market 2014-2018

49 pages • By Infiniti Research Limited

TechNavio's analysts forecast the Global Imaging Biomarkers market to grow at a CAGR of 15.09 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing prevalence of cancer. The Global Imaging Biomarkers market has also been witnessing the emergence of personalized medicines. However, the...

1 600 2 000 1 280
Nov 2013

Biomarkers: Discovery Techniques and Applications - A Global Market Overview

350 pages • By Industry Experts

The potential offered by biomarkers in shaping the outcomes of clinical trials, identifying new drug targets and developing diagnostic assays for detecting diseases early is immense, which has ensued in a large number of scientific publications coming out over the past two decades. Biomarker research encompasses widespread fields of discipline,...

3 600 4 500 2 880
Nov 2013

Molecular Diagnostics in Cancer Testing

232 pages • By TriMark Publications

Molecular diagnostics is a rapidly-advancing area of research and medicine, with new technologies and applications being continually added. The technologies that come under the umbrella of molecular diagnostics include first-generation amplification, DNA probes, fluorescent in-situ hybridization (FISH), second-generation biochips and microfluidics,...

2 720 3 400 2 176
Nov 2013

Biomarkers Market - ([Discovery Technologies - Proteomics, Genomics, Imaging, Bioinformatics], Validation Services, Applications [drug development, personalized medicine], Diseases [Oncology, Cardiology, Neurology]) - Global Trends & Forecasts (2013 – 201

327 pages • By MarketsandMarkets

Biomarkers Market - ([Discovery Technologies - Proteomics, Genomics, Imaging, Bioinformatics], Validation Services, Applications [drug development, personalized medicine], Diseases [Oncology, Cardiology, Neurology]) - Global Trends & Forecasts (2013 – 2018) A biomarker is an identifiable and measurable characteristic, which...

3 720 4 650 2 976
Sep 2013

Companion Biomarkers in Drug Development

356 pages • By TriMark Publications

Companion biomarkers are diagnostic tests that are specifically linked to a therapeutic drug either during its development or in the clinic. This linkage can be an important component of the drug development process; alternatively, the companion biomarker can be useful in ameliorating the regulatory process for the drug, or acting as an aid...

2 720 3 400 2 176
Aug 2013

Biomarkers: Technological and Commercial Outlook 2013-2023

178 pages • By Visiongain

Report DetailsBiomarkers - how to find R&D trends and potential salesWhat's the outlook for biomarkers? Visiongain's updated report predicts revenues to 2023. There you find the best places for sales growth, also understanding trends and opportunities.That study gives you revenue forecasts to 2023 at overall...

2 141 2 633 1 691
Jul 2013

PharmaFocus: Biomarkers in Alzheimer’s Disease

179 pages • By Global Data

PharmaFocus: Biomarkers in Alzheimer’s Disease SummaryAlzheimer’s disease (AD) is a progressive neurodegenerative disease that is characterized by memory loss, cognitive impairment, and functional decline. The disease has emerged as a major global health priority especially because of its rapidly accelerating...

3 196 3 995 2 557
Jun 2013

Personalized Medicine Market Analysis

90 pages • By RNCOS

Advancements in the field of genomics have created ample opportunities for personalized medicines to emerge in the healthcare industry. Personalized medicine represents an interface of therapeutics and diagnostics. It involves the tailoring of treatments as per individuals. The growing research applications and identification of molecular...

960 1 200 768
May 2013

Advances in Disease Theranostics (Technical Insights)

By Frost & Sullivan

This research service analyses the latest developments that has occurred in the field of theranostics, both from a technology and industry perspective.

4 792 5 990 3 834
May 2013

Cancer Diagnostic Testing World Markets

336 pages • By TriMark Publications

Cancer testing is one of the most important growth opportunities for the next three to five years in the diagnostics segment. The National Cancer Institute estimates that about ten million Americans have or have had some form of cancer. Overall costs of the disease are $126 billion annually. Pharmaceutical companies are developing more than...

2 720 3 400 2 176
May 2013

Central Nervous System (CNS) Biomarkers: Technologies and Global Markets

153 pages • By BCC Research

REPORT SCOPEINTRODUCTIONBiomarkers are measurable and quantifiable biological indicators that can be used to diagnose or predict disease, monitor disease progression, indicate what treatment options may be most effective in an individual patient’s case and predict treatment response. They play a role both in...

5 320 6 650 4 256
Mar 2013